Bionomics Limited
BNOEFOTCHealthcare
$0.01
$-0.00(-14.89%)
Market Cap$8812440
P/E Ratio—
52W High$0.055
52W Low$0.0013
Bionomics Limited (BNOEF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BNOEF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: May 20, 2025EPS Actual
$0.66
Revenue
$0.01B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 20, 2025
After Market Close
BNOEF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2025 | May 20, 2025 | — | $0.66 | — | $0.01B | — | — |
| — Q1 FY2025 | Feb 14, 2025 | — | -$0.11 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$0.03 | — | — | — | — |
| — Q3 FY2024 | Sep 30, 2024 | — | -$0.01 | — | $-0.00B | — | — |
| — Q3 FY2023 | Sep 29, 2023 | — | -$0.37 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.40 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Oct 14, 2022 | — | -$0.44 | — | $0.00B | — | — |
Q2 FY2025
May 20, 2025
EPS Actual
$0.66
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Feb 14, 2025
EPS Actual
-$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 30, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.00B
Q3 FY2023
Sep 29, 2023
EPS Actual
-$0.37
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.40
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Oct 14, 2022
EPS Actual
-$0.44
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for BNOEF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | May 20, 2025 | — | $0.01 | — | — |
| — Q1 FY2025 | Feb 14, 2025 | — | $0.01 | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | $0.01 | — | — |
| — Q3 FY2024 | Sep 30, 2024 | — | $0.01 | — | — |
| — Q3 FY2023 | Sep 29, 2023 | — | $0.01 | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.01 | $0.03 | +249.00% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.01 | $0.03 | +249.00% |
| — Q4 FY2022 | Oct 14, 2022 | — | $0.05 | $0.04 | -16.93% |
Q2 FY2025—
Report Date
May 20, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q1 FY2025—
Report Date
Feb 14, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q4 FY2024—
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q3 FY2024—
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q3 FY2023—
Report Date
Sep 29, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q1 FY2023+249.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.03
Q1 FY2023+249.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.03
Q4 FY2022-16.93%
Report Date
Oct 14, 2022
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.04
Beat Rate0 / 8 quarters
Largest Move+249.00% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BNOEF ends December
Bionomics Limited (BNOEF) most recently reported earnings on May 20, 2025 for Q2 FY2025, posting EPS of $0.66 (in line with the analyst consensus of —). The next BNOEF earnings date is expected around September 1, 2026.
Each quarter, investors track BNOEF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BNOEF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BNOEF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BNOEF earnings · 4 questionsBionomics Limited's next earnings report is expected around September 1, 2026. BNOEF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BNOEF historically reports after market close (AMC).
BNOEF earnings datewhen is BNOEF earningsBNOEF next earnings datewhen does BNOEF report earningsBNOEF earnings calendar
▸ Source: FMP · Bionomics Limited SEC filings · US GAAP · Bionomics Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026